Offer - Urjas Oil for just ₹ 1 X
Quikhale SF 250 mcg Capsule, a prescription drug, is manufactured in various forms such as Capsule. The alternative uses of Quikhale SF 250 mcg Capsule have also been explained below.
The correct dosage of Quikhale SF 250 mcg Capsule depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Quikhale SF 250 mcg Capsule are Shortness of Breath, Throat Irritation, Nosebleed. While these are the most often observed Quikhale SF 250 mcg Capsule side effects, there are can be others also. These have been listed below. These side effects of Quikhale SF 250 mcg Capsule are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Quikhale SF 250 mcg Capsule's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Quikhale SF 250 mcg Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Quikhale SF 250 mcg Capsule related warnings section.
Some other conditions that can be affected by Quikhale SF 250 mcg Capsule are listed in the contraindications section below.
Drug reaction of Quikhale SF 250 mcg Capsule with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Quikhale SF 250 mcg Capsule, it is important to know that it is safe while driving, and is habit-forming.
Quikhale SF 250 mcg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Quikhale SF 250 mcg Capsule safe for pregnant women?
Quikhale SF may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Quikhale SF again without your doctor's advice.
Is the use of Quikhale SF 250 mcg Capsule safe during breastfeeding?
Breastfeeding women can take Quikhale SF as it bears very minor side effects for them.
What is the effect of Quikhale SF 250 mcg Capsule on the Kidneys?
Quikhale SF is completely safe for kidneys.
What is the effect of Quikhale SF 250 mcg Capsule on the Liver?
Quikhale SF may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Quikhale SF 250 mcg Capsule on the Heart?
You may experience side effects on your heart after taking Quikhale SF. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Quikhale SF 250 mcg Capsule unless your doctor advises you to do so -
Is this Quikhale SF 250 mcg Capsule habit forming or addictive?
No, you will not get addicted to Quikhale SF 250 mcg Capsule.
Interaction between Food and Quikhale SF 250 mcg Capsule
There isn't any research available on the side effects of taking Quikhale SF 250 mcg Capsule with food.
Interaction between Alcohol and Quikhale SF 250 mcg Capsule
It is difficult to say anything about the effect of Quikhale SF 250 mcg Capsule and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359